Bing

In dismissing the offer, Baxalta argues its shares have not yet achieved a price level that appropriately reflect its prospects, since it was only spun off from Baxter International (BAX.N) last month. "We expect that our stock will move up in price and ...
Reuters · ByBen Hirschler andSinead Cruise · 8/10/2015
LONDON (Reuters) - Drugmaker Shire SHP.L said on Tuesday it was seeking to buy Baxalta BXLT.N, a company spun-off by Baxter International BAX.N last month ... up nearly 12 percent at $37.10. Shire's stock closed down about 6 percent.
Reuters · ByPaul Sandle · 8/4/2015
The company said that it cut the jobs at its BAX unit as part of a revamping to reduce capacity and costs at its air transportation business. Shares of the company, based in Richmond, Va., fell $2.41, to $18.40, on the New York Stock Exchange.
New York Times · 2/2/2001
LONDON Drugmaker Shire (SHP.L) said on Tuesday it was seeking to buy Baxalta (BXLT.N), a company spun-off by Baxter International (BAX.N) last month ... closed up nearly 12 percent at $37.10. Shire's stock closed down about 6 percent.
Firstpost · 8/4/2015
The worst performer was Baxter International Inc (NYSE:BAX) after the Deerfield ... Build completed its spin-off of the contracting services company. On the New York Stock Exchange, advancing issues outnumbered decliners by a 1,971 to 1,181 margin.
Money Control · 7/2/2015
LivingSocial was once considered a possible IPO, but the prospects on that have cooled and Citi’s report on their meeting with CEO Tim O’Shaugnessy and CFO John Bax doesn’t discuss ... as a public company (see, 56% stock drop and fired …
The Wall Street Journal · ByDavid Benoit · 8/5/2013
(By Mani) Baxter International Inc.'s (NYSE: BAX) $4 billion deal to buy Sweden's Gambro AB is a good strategic fit for the healthcare company. However, the deal comes at a premium price hinting some integration risks. Deerfield, Illinois-based Baxter ...
istock Analyst · 12/6/2012
Baxalta only started life as an independent company recently, its former owner - US drugs giant Baxter (US:BAX) - spun it off in early July ... The current bid is based on an all-stock consideration (allegedly for tax purposes), and the $45.23 per share ...
Investors Chronicle · 8/5/2015
Baxter issued a conservative long-term outlook last week, saying its focus on treatments for unmet medical needs would help insulate it from macroeconomic pressures. Shares of the company closed at $61.92 on Wednesday on the New York Stock
Chicago Tribune · 10/18/2012
This month I like to show you the best yielding large cap stocks from all sectors that are less volatile than the market ... Here are my favorite stocks: Baxter International (BAX) has a market capitalization of $39.47 billion. The company employs 51,000 ...
Trefis · 4/2/2013

Baxter International

Company
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to tr…
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had 2013 sales of $15.3 billion, across two businesses: BioScience and Medical Products. Baxter’s BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine; and vaccines. Baxter’s Medical Products business produces intravenous solutions and other products used in the delivery of fluids and drugs to patients; inhalation anesthetics; contract manufacturing services; and products to …
Data from: Wikipedia